Concepedia

John Sullivan

JS

Statistics

Publications

16

Citations

1.5K

H-Index

13

Active since

1969

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Pfizer (United Kingdom)

Case Western Reserve University

Kettering University

Cincinnati Children's Hospital Medical Center

John Sullivan is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

1969–2020

16

Publications

16

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

Gerd Fätkenheuer, Anton Pozniak, Margaret Johnson et al. · Nature Medicine · 2005 · 491 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, RTEL1, Underlies Severe Immunodeficiency and Features of Hoyeraal Hreidarsson Syndrome

Bari J. Ballew, Joseph Vijai, Saurav De et al. · PLoS Genetics · 2013 · 140 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Ring-current effect of the phthalocyanine ring

Thomas R. Janson, Alexander R. Kane, John Sullivan et al. · Journal of the American Chemical Society · 1969 · 92 citations

Natural Sciences, Chemistry, Analytical Chemistry +6

Valsartan in heart failure patients previously untreated with an ACE inhibitor

V. P. Mazayev, V. A. Sulimov, T.V Zvereva et al. · International Journal of Cardiology · 1998 · 90 citations

Medicine, Cardiology, Pharmacology +11

1–5 of 16